HMCIB No.7 SPECIAL PURPOSE ACQUISITION (477340) Fundamentals 2026 — P/E 62.5x, Revenue Analysis | SniperIQ
HMCIB No.7 SPECIAL PURPOSE ACQUISITION (477340) is a KR-listed Financial Services company in Financial - Conglomerates with a market capitalization of ₩15.3B, trading at ₩2035.00 on the KOE. This SniperIQ fundamentals page covers HMCIB No.7 SPECIAL PURPOSE ACQUISITION's valuation (P/E 62.5x, P/B 1.0x), profitability (net margin -1965.3%), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is HMCIB No.7 SPECIAL PURPOSE ACQUISITION's market cap?
HMCIB No.7 SPECIAL PURPOSE ACQUISITION (477340) has a market capitalization of approximately ₩15.3B, trading at ₩2035.00 on the KOE. Market cap moves with the live share price.
What is HMCIB No.7 SPECIAL PURPOSE ACQUISITION's P/E ratio?
HMCIB No.7 SPECIAL PURPOSE ACQUISITION's trailing twelve-month P/E ratio is 62.5x, with a price-to-book (P/B) of 1.0x. Valuation multiples are best compared with Financial Services sector peers rather than read in isolation.
How profitable is HMCIB No.7 SPECIAL PURPOSE ACQUISITION?
HMCIB No.7 SPECIAL PURPOSE ACQUISITION runs a net profit margin of -1965.3%, a gross margin of 100.0%, and an operating margin of 235.3%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
Does HMCIB No.7 SPECIAL PURPOSE ACQUISITION pay a dividend?
HMCIB No.7 SPECIAL PURPOSE ACQUISITION does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.
Is HMCIB No.7 SPECIAL PURPOSE ACQUISITION financially healthy?
HMCIB No.7 SPECIAL PURPOSE ACQUISITION carries a debt-to-equity ratio of 0.08x and a current ratio of 0.00x, with a market beta of 0.02. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is HMCIB No.7 SPECIAL PURPOSE ACQUISITION a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For HMCIB No.7 SPECIAL PURPOSE ACQUISITION (477340) the key facts are: market cap ₩15.3B, P/E 62.5x, 52-week range 1990-2050. Weigh valuation, profitability, growth, and balance-sheet strength against Financial Services peers and form your own view.
Track HMCIB No.7 SPECIAL PURPOSE ACQUISITION's full fundamentals live
Get HMCIB No.7 SPECIAL PURPOSE ACQUISITION's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.